Novo Nordisk beats estimates, raises guidance on Wegovy pill surge
Novo Nordisk beats estimates, raises guidance on Wegovy pill surge Proactive uses images sourced from Shutterstock Novo Nordisk…
Novo Nordisk (NVO) lifts 2026 outlook as obesity drug demand remains strong
Wegovy ©Novo Nordisk Novo Nordisk (NYSE:NVO) raised its full-year guidance on Wednesday, citing continued strong demand for its…
Novo Nordisk’s sales increased by 6% in Danish kroner and by 10% at constant exchange rates to DKK 309.1 billion in 2025
Novo Nordisk A/S Bagsværd, Denmark 3 February 2026 – Financial report for the period 1 January 2025 to…
Novo Nordisk’s sales increased by 6% in Danish kroner and by 10% at constant exchange rates to DKK 309.1 billion in 2025
Novo Nordisk A/S Bagsværd, Denmark 3 February 2026 – Financial report for the period 1 January 2025 to…